InvestorsHub Logo
Followers 6
Posts 601
Boards Moderated 0
Alias Born 09/05/2013

Re: coldasice post# 10161

Friday, 01/22/2016 10:54:17 AM

Friday, January 22, 2016 10:54:17 AM

Post# of 12137
Like the way you think, just have a hard time believing we can reach 50million sales in 2 years. We'll find out in a couple weeks if their projections are still possible. As for the warrants, the share price is so much lower at the moment I'd be taking advantage of that instead...oh yeah, I am taking advantage of itwink Let those warrants expire. The value of the portal is total crap shoot, as seldom does the 'expense' of a program equate to its value, could be 10 times or 100 times that, or it could be worthless in a fire sale. What I need to see is not only revenue growth, but gross margin improvement. Seems we've been seeing similar loss numbers no matter what the revenues, how many more 'clinical trial' companies can we take on if we lose money on every one? This statement is worrisome since gross margin hasn't budged even though revenues have grown substantially...

-- Gross margin for the three and six month periods ended September 30, 2015 was 30% and 32%, respectively, compared to 27% and 32% for the same periods in the prior year. The Company's gross margin target continues to be 60%, which can be expected when cash flow break even is achieved.

So we need 60% gross margin to be cash flow positive? That appears to be quite a ways out when revenues almost double but no better margin. I do realize they have little revenue yet to support a world wide operation really, no way they could operate without many good partnerships in place...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News